,

Yufei Xiang1, Jialu Xu2, Briana L McGovern3

  • 1Center of Protein Engineering and Therapeutics, Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

Cell
|October 24, 2024
PubMed
概括

一个新的纳米体平台AMETA使用多个结合点来制造针对SARS-CoV-2等不断发展的病原体的强有力的抗病毒药物. 在临床前研究中,这种适应性多层向与增强性向 (AMETA) 平台显示出广泛而持久的疗效.